EXAS - Company ID 0001124140
The table below shows EXACT SCIENCES CORP's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $850.74M | $811.09M | $706.78M | $713.42M | $708.65M | $699.26M |
| Cost of revenue | $266.81M | $248.63M | $206.24M | $220.83M | $217.17M | $210.95M |
| Gross profit | $583.93M | $562.45M | $500.55M | $492.59M | $491.49M | $488.32M |
| R&D | $117.29M | $108.90M | $105.31M | $97.71M | $101.49M | $121.14M |
EXACT SCIENCES CORP reported annual revenue of $3.25B for fiscal year 2025. That is up 17.7% from $2.76B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $99.38M (FY 2016) to $3.25B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $241.41M | $208.58M | $220.69M | $191.11M | $193.54M | $177.52M |
| Operating income | -$25.55M | -$2.15M | -$96.01M | -$876.35M | -$39.40M | -$26.26M |
| Income tax | $1.84M | $1.13M | $224.00K | -$11.38M | $808.00K | $1.46M |
| Net income | -$19.59M | -$1.19M | -$101.22M | -$864.59M | -$38.24M | -$15.81M |
| EPS (diluted) | -$0.10 | -$0.01 | -$0.54 | -$4.67 | -$0.21 | -$0.09 |